Former HOT at ICN gets CFO job at Watson
Posted By Chris Bale on November 1, 2009
Watson Pharmaceuticals jas announced that R. Todd Joyce has been named Senior Vice President and Chief Financial Officer (CFO) effective immediately. Mr. Joyce succeeds Mark W. Durand, who has departed as CFO for personal reasons. On July 27, 2009, Watson announced that Mr. Durand had taken a leave of absence for health reasons, and named Mr. Joyce as Acting Principal Financial Officer.
Mr. Joyce joined Watson in
*****
You need to be logged in to see this part of the post. Login using the box in the sidebar. Not registered? Click here to register
*****
Watson Pharmaceuticals, Inc., (NYSE: WPI) is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).
Comments
Leave a Reply
You must be logged in to post a comment.